Nes-Ziona, Israel, April 03, 2023 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, “Enlivex”), a…
Based on interim efficacy and safety data, Independent Data Monitoring Committee recommends continuation of the…
Based on interim efficacy and safety data, Independent Data Monitoring Committee recommends continuation of the…
REDWOOD CITY, Calif., April 03, 2023 (GLOBE NEWSWIRE) — PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”),…
REDWOOD CITY, Calif., April 03, 2023 (GLOBE NEWSWIRE) — PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”),…
Pomotrelvir did not meet the primary endpoint measured by proportion of participants below the limit…
Pomotrelvir did not meet the primary endpoint measured by proportion of participants below the limit…
BOSTON, April 03, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an…
BOSTON, April 03, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an…
Three patients now dosed in Phase 2 clinical study evaluating ELX-02 for the treatment of…
Three patients now dosed in Phase 2 clinical study evaluating ELX-02 for the treatment of…
Expect to complete patient enrollment in the randomized Phase 1/2a SIGNAL-AD Alzheimer’s study in April…
Expect to complete patient enrollment in the randomized Phase 1/2a SIGNAL-AD Alzheimer’s study in April…
WARRINGTON, Pa., April 03, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology…
WARRINGTON, Pa., April 03, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology…
Biosimilar Hyrimoz® (adalimumab) citrate-free high-concentration formulation (HCF) is now approved in the EU for use…
Biosimilar Hyrimoz® (adalimumab) citrate-free high-concentration formulation (HCF) is now approved in the EU for use…
Program for HR startups-to-watch includes mentoring and a $160,000 equity investment from SHRM Confirm brings…
Program for HR startups-to-watch includes mentoring and a $160,000 equity investment from SHRM Confirm brings…
Figure 1: Detailed geological map of the Swan mineralized zone. VANCOUVER, British Columbia, April 03,…